China controlled the virus and economy boomed. new mega projects, space technology, military advancement..... all progressed in leaps and bounds in 2020.
Congrats. The rest of the world won't really see 2020 and China the same way till - well eternity.
Even if Chinese vaccines magically work, his nation can barely manufacture enough for their own population
99 recipients have adverse reactions, 2 hospitalised
TNN | Jan 17, 2021, 05:41 IST
NEW DELHI: Ninety-nine people across India experienced adverse reactions after being vaccinated on Saturday but only two were considered serious enough to require hospitalisation.
However, central officials said there were no reports of adverse effects requiring hospitalisation till Saturday evening, Eleven adverse reactions were noticed in Telangana, 22 in Maharashtra (14 of 22 were minor cases), 52 in Delhi and 14 in West Bengal.
Fifty-one out of the 52 healthcare workers in Delhi who had an adverse reaction were minor adverse events. One adverse event, which required hospital admission, was reported late Saturday evening from AIIMS where the healthcare worker had been admitted.
In Kolkata, top health official Ajay Chakravorty said that all but one of the 14 who had experienced adverse reactions had been allowed to go home after an hour’s observation.
99 recipients have adverse reactions, 2 hospitalised | India News - Times of India
India News: NEW DELHI: Ninety-nine people across India experienced adverse reactions after being vaccinated on Saturday but only two were considered serious enoug.timesofindia.indiatimes.com
(Bloomberg) -- Of all the developing countries testing China’s Covid-19 vaccines, few are friendlier to Beijing than Pakistan. In the years leading up to the pandemic, China financed nearly $70 billion across the South Asian nation on roads, railways and power stations, and Pakistan now has two Chinese clinical trials underway, with even senior government officials being inoculated.
Yet interviews with people in Karachi, the nation’s biggest city -- as well as in other developing nations from Indonesia to Brazil, together with surveys and official comments -- show that China has failed to assure the millions of people who may have to rely on its vaccines.
“I won’t take it,” said Farman Ali Shah, a motorcycle driver in Karachi for local ride-hailing app Bykea, as local shops closed early ahead of an 8 p.m. virus-induced curfew. “I don’t trust it.”
China Is Struggling to Get the World to Trust Its Vaccines
Mistrust of poorer nations on China to inoculate their populations could set the stage for a major global political headache .www.bloombergquint.com
When you Indians learn from wean off your former western masters?
As long as Chairman Mao is worshipped
I doubt that's a country wide phenomenon.
Is that what they tell the Chinese citizens to prevent more Chinese refugees joining the 100000 Chinese refugees in India?
Doubts of vaccine safety linger as India rolled out the so-called world's largest vaccination program starting this weekend. At least one death and 447 cases of side effects were reported among 224,000 people, reports said.
The vaccination in India is a test case that will determine whether the epidemic can be tamed by vaccination in developing nations, but Chinese observers doubt whether 300 million high-risk people in India can be covered, including healthcare and frontline workers, as it can scheduled and ensure a certain level of safety.
While India kicked off on Saturday what Indian authorities have called the "the world's largest vaccination drive" and boasted the safety of vaccines, the country reported one death-- a 46-year-old medical worker. He died one day after the vaccination, but doctors dismissed the direct link between his death to the vaccine safety.
The country inoculated more than 224,000 people in two days, and 447 adverse cases were reported, according to Hindustan Times.
India Today also reported on the first day of the vaccination program that of 4,319 health workers vaccinated, there was one severe and 51 minor cases of adverse effects.
India hopes to be one of the world-leading coronavirus vaccine providers as it eyes great global markets for the vaccine demand. However, whether it is able to guarantee the safety and efficacy of the vaccines remains a question, Lü Mengtao, a medical industry observer, told the Global Times on Monday.
Despite starting mass vaccinations, India's domestic vaccine has no clear data on its efficacy and safety, but Indian officials and media have sought to dispel the fears.
"Fifty-one adverse cases out of 4,319 vaccinations are not a good rate for vaccine safety. If the death has a direct link with the vaccine, the vaccination process may have to be called off for the sake of public safety," Lü said.
Vaccines used in the program are the two authorized for emergency use earlier this month - one is Covishield, developed with British-Swedish biopharmaceutical company AstraZeneca and Oxford University, and the other one, Covaxin, was domestically developed by Indian firm Bharat Biotech.
Indian reports also said on the first day of the vaccine scheme, a large number of registered health workers did not show up and Indian authorities are mobilizing them to receive shots.
In the first phase of the program, which will last until August, Indian plans to vaccinate 300 million high-risk people, but Chinese observers said India may not complete the vaccination scheme as planned due to its limited medical conditions and a high level of population mobility in some rural areas and slums.
www.reuters.com
